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INCREASED SEVERITY OF SYNOVIAL HYPERTROPHY BY ULTRASOUND
IN KNEE OSTEOARTHRITIS OF SHORTER DISEASE DURATION
N. Navarro, C. Orellana, J. Calvet, M. Garcı´a-Manrique, J. Grataco´s,
M. Larrosa. Hosp. de Sabadell (Parc Taul´ı), Sabadell, Spain
Purpose: To analyze whether the existence or severity of inﬂammatory
changes as detected by ultrasound (synovial effusion and /or
hypertrophy) are related to disease duration in patients with knee
osteoarthritis.
Methods: Patients aged 50 y or more with symptomatic osteoarthritis
of the knee and joint effusion, Kellgren-Lawrence II-III. Demographics,
BMI, duration from onset of symptoms, pain assessed by VAS (0–10 cm)
and the Lequesne index algofuncional were analyzed in a cross-sectional
study. Knee ultrasound was performed evaluating and measuring the
presence of effusion and synovial hypertrophy at the suprapatellar
midline. Two groups were established depending on whether the
evolution time from the onset of symptoms was less than or equal
to or greater than 2 years.
Results: Thirty patients were analyzed, F/M 29/6, age 61.7±9.6 y, disease
duration 46.1±43 months, BMI 30.6±4.9 kg/cm2. Disease duration was
≤ 2 years in 19 patients (54.3%). There were no differences according
to disease duration with regard to age, BMI or radiological grade.
Patients with osteoarthritis of the knee with less evolution time
showed a moderate tendency to have a greater joint effusion (7±3.1
vs. 6.6±2.6mm, ns). Synovial hypertrophy was signiﬁcantly greater in
the shorter duration group (6.9±2.1 vs. 4.1±2.1mm, P< 0.005) and also
showed a tendency to have higher pain by VAS (6.5±1.5 vs. 5.9±2.6, ns).
On the other hand, patients with a longer history of knee OA showed
signiﬁcantly higher scores on the Lequesne index (11.3±4 vs. 8.4±2.6,
p < 0.05).
Conclusions: In this sample of patients with symptomatic knee OA,
synovial hypertrophy had a greater thickness in patients with shorter
disease duration. This ﬁnding could be related to the existence of pain
in the early stages of the disease.
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ASSOCIATION BETWEEN METABOLIC SYNDROME AND SYNOVITIS
IN PATIENTS WITH KNEE OSTEOARTHRITIS
C. Orellana, N. Navarro, I. Va´zquez, M. Moreno, C. Galisteo, J. Grataco´s,
M. Larrosa. Hosp. de Sabadell (Parc Taul´ı), Sabadell, Spain
Purpose: To assess whether patients with knee osteoarthritis and
metabolic syndrome have an increased frequency of inﬂammatory
features as detected by ultrasound.
Methods: Patients aged 50 years or more with symptomatic
osteoarthritis of the knee and joint effusion, Kellgren-Lawrence II-III.
Demographics, BMI, disease duration, pain assessed by VAS (0–10 cm),
algofuncional Lequesne index and the existence of metabolic syndrome
(ATP III criteria) were assessed. Knee ultrasound was performed
evaluating and measuring the presence of effusion and synovial
hypertrophy at the suprapatellar midline.
Results: We analyzed 35 patients, F/M 29/6, age 61.7±9.6 y, disease
duration 46.1±43 months, BMI 30.6±4.9 kg/cm2. Eight patients (22.9%)
met diagnostic criteria for metabolic syndrome. There were no signiﬁcant
differences in age, BMI or radiological grade. Patients with metabolic
syndrome had a higher mean duration (76.6 vs. 37.2 months, p< 0.05).
In patients with metabolic syndrome there was a clear trend, although
not statistically signiﬁcant, to have a more prominent joint effusion
(7.2±2.7 vs. 6.2±3.2mm) and a greater percentage of patients with
signiﬁcant synovial hypertrophy (>4mm) (5/8 (62.5%) vs. 14/27 (51.9%),
while no difference was evident in relation to the average thickness of
the hypertrophy in patients with synovitis in both groups. Patients with
metabolic syndrome had higher pain (VAS 6.2±1.5 vs. 5.8±1.9, ns) and
higher scores on the Lequesne index (12.1±4.5 vs. 9±2.9, p < 0.05).
Conclusions: In this sample of patients with symptomatic knee
osteoarthritis, comorbidity in the form of metabolic syndrome was
associated with greater functional impairment as measured by the
Lequesne index and a nonsigniﬁcant trend (probably related to small
sample size) to show higher prevalence of hypertrophic synovium and
increased synovial effusion.
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ENDOGENOUS PARATHYROID HORMONE IS ASSOCIATED WITH
REDUCED CARTILAGE VOLUME IN VIVO IN A POPULATION-BASED
SAMPLE OF ADULT WOMEN
S. Brennan1, F. Cicuttini1, J. Pasco2, M. Kotowicz3, M. Henry2,
G. Nicholson4, A. Wluka1. 1Monash Univ., Melbourne, Australia; 2Deakin
Univ., Geelong, Australia; 3Barwon Hlth., Geelong, Australia; 4Univ. of
Queensland, St Lucia, Australia
Purpose: Parathyroid hormone(PTH) has complex actions on bone when
administered exogenously, and intermittent injection is anabolic to bone.
Current data suggest that exogenous PTH may exert a positive inﬂuence
upon cartilage after injury. However, little are known about endogenous
PTH and cartilage in vivo, and the role PTH may play in changes to knee
structure, as precursors to the onset or progression of osteoarthritis.
Thus, the aim of this study was to examine the association between
endogenous PTH and cartilage volume in a healthy adult population
without any signs of osteoarthritis.
Methods:Magnetic resonance imaging of the knee was performed on 101
asymptomatic females aged 35–49 years(2007–9). Blood samples(PTH
and vitamin D) were obtained 10 years prior(1994–7), and stored at
−80°C for random batch analyses. Serum intact PTH was quantiﬁed
by chemiluminescent enzyme assay. Serum vitamin D(25[OH]D) was
assayed using an equilibrium radioimmunoassay after extraction with
acetonitrile.
Results: After adjustment for age, BMI and bone area, a 1-unit(pmol/L)
increase in PTH was associated with reduced medial cartilage volume
[regression coefﬁcient ± standard deviation, p value](−0.7±0.3, p = 0.03).
Further adjustment for seasonal variation increased the strength of
association(−0.8±0.3, p = 0.01), however results were similar after further
adjustment for 25[OH]D(−0.08±0.4, p = 0.03). No associations were
observed with lateral cartilage volume (0.2≤p≤0.5). All results remained
signiﬁcant(p < 0.01) after excluding subjects with osteophytes to account
for the possibility of pre-clinical osteoarthritis.
Conclusions: This study suggests greater levels of PTH might be
detrimental to cartilage in vivo in humans. High PTH may reduce
the ability of cartilage to heal following injury, similar to the reduced
healing ability of cartilage observed in animal studies. These data suggest
a limited regenerative capability of cartilage in the presence of high
endogenous PTH.
Clinical Trials
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DEXTROSE PROLOTHERAPY FOR KNEE OSTEOARTHRITIS: RESULTS
OF A RANDOMIZED CONTROLLED TRIAL
D.P. Rabago, D.J. Miller, A.E. Zgierska, M. Mundt, R.X. Kijowski, B. Jessica,
J.J. Patterson. Univ. of Wisconsin Sch. of Med. and Publ. Hlth., Madison, WI,
USA
Purpose: Knee osteoarthritis (KOA) is common, expensive and
debilitating. Sources of pain include the joint capsule, ligaments,
synovium, bone, menisci and extra-articular ligament and tendon
attachments. Prolotherapy is a complementary and alternative injection
therapy for chronic musculoskeletal pain including KOA hypothesized to
stimulate healing of chronically injured tissue. Prolotherapy injections
directly target the multiple pain-generating structures associated with
KOA in and around the knee, but is poorly studied.
Methods: The objective of our study was to assess the efﬁcacy of
prolotherapy for chronic KOA in an NIH-NCCAM funded study. We
conducted a 3-arm (prolotherapy, saline injections, at-home exercise)
randomized controlled trial. The injector, all assessors and injection
group subjects were blind to group allocation. Adult subjects were
recruited from outpatient settings. Inclusion criteria included at least
3 months of symptomatic KOA and clinically determined KOA using
American Rheumatological Association criteria. Blinded injections were
performed at 1, 5, and 9 weeks with as-needed injection sessions at
weeks 13 and 17. Extra-articular injections were done at peri-articular
tendon and ligament insertions. A single intra-articular injection was
performed through an infero-medial approach. Extra- and intra-articular
prolotherapy injections were 15% and 25% dextrose respectively; control
injections were saline. Exercise subjects received an exercise manual and
